medGadget -- To evaluate how tumor cells from an individual cancer patient might react to chemotherapy drugs, researchers from Technische Universität München (TUM) developed a tiny microfluidic device that can automate the testing process.
medGadget -- To evaluate how tumor cells from an individual cancer patient might react to chemotherapy drugs, researchers from Technische Universität München (TUM) developed a tiny microfluidic device that can automate the testing process.